<p><strong>Oral (Adult)-</strong><br />
<br />
<strong>Herpes zoster (shingles):</strong>&nbsp;500 mg tid for 7 days. Immunocompromised patients: 500 mg tid for 10 days.<br />
<br />
Haemodialysis patients: 250 mg after each dialysis run during 7 days. Immunocompromised patients: Same dose but treatment is given for 10 days.</p>

<ul>
	<li>CrCl (mL/min) &lt;20: 250 mg once daily for 7 days.</li>
	<li>CrCl (mL/min) 20-39: 500 mg once daily for 7 days.</li>
	<li>CrCl (mL/min) 40-59: 500 mg bid for 7 days.</li>
</ul>

<p><strong>Recurrent herpes labialis:</strong>&nbsp;1.5 g as a single dose.<br />
<br />
Haemodialysis patients: 250 mg after dialysis run.</p>

<ul>
	<li>CrCl (mL/min) &lt;20: 250 mg as a single dose.</li>
	<li>CrCl (mL/min) 20-39: 500 mg as a single dose.</li>
	<li>CrCl (mL/min) 40-59: 750 mg as a single dose.</li>
</ul>

<p><strong>Genital herpes:</strong>&nbsp;1st episode: 250 mg tid for 5 days. Immunocompromised patients: 500 mg bid for 7 days.<br />
<br />
Haemodialysis patients: 250 mg after each dialysis run during 5 days.</p>

<ul>
	<li>CrCl (mL/min) &lt;20: 250 mg once daily for 5 days.</li>
	<li>CrCl (mL/min) 20-39: 250 mg bid for 5 days.</li>
</ul>

<p><strong>Acute treatment of recurrent mucocutaneous herpes in HIV-infected patients:</strong>&nbsp;500 mg bid for 7 days.<br />
<br />
Haemodialysis patients: 250 mg after each dialysis run during 7 days.</p>

<ul>
	<li>CrCl (mL/min) &lt;20: 250 mg once daily for 7 days.</li>
	<li>CrCl (mL/min) 20-39: 500 mg once daily for 7 days.</li>
</ul>

<p><strong>Acute treatment of recurrent episodes of genital herpes:</strong>&nbsp;125 mg bid for 5 days or 1 g bid for 1 day. Immunocompromised patients: 500 mg bid for 7 days.<br />
<br />
Haemodialysis patients: 125 mg after each dialysis run during 5 days. Haemodialysis patients (immunocompromised): 250 mg after each dialysis run during 7 days.</p>

<ul>
	<li>CrCl (mL/min) &lt;20: 125 mg once daily for 5 days.</li>
	<li>CrCl (mL/min) &ge;20: 125 mg bid for 5 days.</li>
	<li>CrCl (mL/min) &lt;20: Immunocompromised: 250 mg once daily for 7 days.</li>
	<li>CrCl (mL/min) 20-39: Immunocompromised: 500 mg once daily for 7 days.</li>
</ul>

<p><strong>Suppression of recurrent episodes of genital herpes:</strong>&nbsp;250 mg bid. Immunocompromised patients: 500 mg bid. Suppressive treatment is interrupted every 6-12 mth for observation.<br />
<br />
Haemodialysis patients: 125 mg after each dialysis run. Haemodialysis patients (immunocompromised): 250 mg after each dialysis run.</p>

<ul>
	<li>CrCl (mL/min) 20: 125 mg once daily. Immunocompromised: 250 mg once daily.</li>
	<li>CrCl (mL/min) 20-39: 125 mg bid. Immunocompromised: 500 mg once daily.</li>
</ul>